SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-011781
Filing Date
2021-08-16
Accepted
2021-08-16 11:18:52
Documents
14
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20210816x8k.htm   iXBRL 8-K 34721
2 EX-99.1 rsls-20210816xex99d1.htm EX-99.1 279497
3 GRAPHIC rsls-20210816xex99d1001.jpg GRAPHIC 18893
  Complete submission text file 0001558370-21-011781.txt   471501

Data Files

Seq Description Document Type Size
4 EX-101.SCH rsls-20210816.xsd EX-101.SCH 2129
5 EX-101.LAB rsls-20210816_lab.xml EX-101.LAB 15389
6 EX-101.PRE rsls-20210816_pre.xml EX-101.PRE 9886
7 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20210816x8k_htm.xml XML 4675
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 211175597
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences